Tobacco nitrosamines as culprits in disease: mechanisms reviewed

Emine Yalcin1, Suzanne de la Monte2

  • 1Departments of Pathology (Neuropathology), Neurology, and Medicine, Rhode Island Hospital and the Warren Alpert Medical School of Brown University, 55 Claverick Street, Room 419, Providence, RI, 02903, USA.

Insights

Tobacco smoke toxins cause cellular damage through metabolic effects and adduct formation, contributing to non-cancerous diseases like neurodegeneration and insulin resistance.

Area of Science:

  • Toxicology
  • Molecular Biology
  • Disease Mechanisms

Background:

  • The carcinogenic link between tobacco and cancer is established.
  • Emerging evidence highlights non-carcinogenic cellular injury from tobacco smoke toxins.
  • These toxins contribute to diseases beyond cancer.

Purpose of the Study:

  • To review the mechanisms by which tobacco smoke toxins cause cellular injury.
  • To explore the role of these toxins in non-cancerous diseases.
  • To summarize current knowledge on nicotine and nitrosamine metabolism and adduct formation.

Main Methods:

  • Review of existing literature on tobacco smoke toxicology.
  • Analysis of metabolic pathways of nicotine and tobacco-specific nitrosamines.
  • Examination of mechanisms of DNA, protein, and lipid adduct formation.
  • Investigation of cellular signaling disruption, oxidative stress, and inflammation.

Main Results:

  • Tobacco toxins induce cellular injury via enhanced metabolism, disrupted signaling, and adduct formation.
  • Adducts impair cellular function, promote oxidative stress, and inflammation.
  • These non-carcinogenic effects are linked to tobacco-specific nitrosamines and their metabolites.
  • These mechanisms may explain increased rates of neurodegeneration and insulin resistance in smokers.

Conclusions:

  • Tobacco smoke contains toxins that cause significant cellular damage beyond cancer.
  • These toxic effects, mediated by metabolites and adducts, contribute to serious non-cancerous diseases.
  • Understanding these pathways is crucial for addressing the full health burden of smoking.

Related Concept Videos

2° Amines to N-Nitrosamines: Reaction with NaNO201:20

2° Amines to N-Nitrosamines: Reaction with NaNO2

Secondary amines react with nitrous acid to form N-nitrosamines, as depicted in Figure 1. Nitrous acid, a weak and unstable acid, is formed in situ from an aqueous solution of sodium nitrite and strong acids, such as hydrochloric acid or sulfuric acid, in cold conditions. In the presence of an acid, the nitrous acid gets protonated. The subsequent loss of water results in the formation of the electrophile known as nitrosonium ion.
5.7K
Spontaneous and Induced Mutations01:30

Spontaneous and Induced Mutations

Spontaneous mutations arise infrequently during DNA replication due to errors in the process. A key factor behind these errors is tautomeric shifts in nitrogenous bases, where bases transition from keto to enol forms or amino to imino forms. This shift can alter base-pairing rules, leading to mutations. Additionally, reactive oxygen species (ROS) arising from aerobic metabolism can damage DNA, resulting in depurination (loss of a purine base) or depyrimidination (loss of a pyrimidine base).
2.9K
Drugs Acting on Autonomic Ganglia: Stimulants01:23

Drugs Acting on Autonomic Ganglia: Stimulants


Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
2.3K
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
2.1K
Bioactivation and Tissue Toxicity01:25

Bioactivation and Tissue Toxicity

Bioactivation is a metabolic process that transforms less reactive substances into highly reactive metabolites, initiating tissue toxicity. This transformation can lead to various toxic effects, including carcinogenesis and teratogenesis. Reactive metabolites are classified into two main types: electrophiles and free radicals.Electrophiles are electron-deficient species and are produced primarily by the enzyme cytochrome P-450 during the metabolism of compounds containing carbon, nitrogen, or...
107
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
8.7K